Ceftriaxone Reconstitution Procedure
For intramuscular administration, reconstitute ceftriaxone powder by adding specific volumes of diluent to achieve either 250 mg/mL or 350 mg/mL concentration, and for intravenous administration, reconstitute to achieve 100 mg/mL concentration before further dilution to 10-40 mg/mL for infusion. 1
Intramuscular Reconstitution
The FDA-approved reconstitution volumes for IM administration are 1:
Standard 250 mg/mL concentration:
- 250 mg vial: Add 0.9 mL diluent
- 500 mg vial: Add 1.8 mL diluent
- 1 gram vial: Add 3.6 mL diluent
- 2 gram vial: Add 7.2 mL diluent
Alternative 350 mg/mL concentration:
- 500 mg vial: Add 1 mL diluent
- 1 gram vial: Add 2.1 mL diluent
- 2 gram vial: Add 4.2 mL diluent
Important caveat: The 350 mg/mL concentration is not recommended for the 250 mg vial since complete withdrawal may not be possible 1.
IM Reconstitution Technique
- Inject diluent into vial
- Shake vial thoroughly to form solution
- Withdraw entire contents into syringe to equal total labeled dose
- Inject deep into large muscle mass with aspiration to avoid intravascular injection 1
Intravenous Reconstitution
Initial reconstitution volumes for IV administration 1:
- 250 mg vial: Add 2.4 mL diluent (yields ~100 mg/mL)
- 500 mg vial: Add 4.8 mL diluent (yields ~100 mg/mL)
- 1 gram vial: Add 9.6 mL diluent (yields ~100 mg/mL)
- 2 gram vial: Add 19.2 mL diluent (yields ~100 mg/mL)
After initial reconstitution, withdraw entire contents and dilute to desired concentration (10-40 mg/mL recommended) with appropriate IV diluent 1.
IV Administration Parameters
- Standard infusion time: 30 minutes for all patients except neonates 1
- Neonatal infusion time: 60 minutes to reduce risk of bilirubin encephalopathy 1
- Target concentration range: 10-40 mg/mL (lower concentrations may be used if desired) 1
Critical Diluent Restrictions
Never use calcium-containing diluents such as Ringer's solution or Hartmann's solution for reconstitution or further dilution, as particulate formation will result 1. This is particularly critical in neonates where ceftriaxone-calcium precipitation can be fatal.
Acceptable Diluents
For both IM and IV reconstitution 1:
- Sterile Water for Injection
- 0.9% Sodium Chloride Solution
- 5% Dextrose Solution
- 10% Dextrose Solution
- Bacteriostatic Water + 0.9% Benzyl Alcohol (IM only)
- 1% Lidocaine Solution without epinephrine (IM only)
Stability After Reconstitution
IM solutions remain stable (less than 10% potency loss) 1:
- Room temperature (25°C): 2 days for most diluents, 24 hours for bacteriostatic water or lidocaine
- Refrigerated (4°C): 10 days for most diluents, 3 days for bacteriostatic water or lidocaine
IV solutions at 10-40 mg/mL remain stable 1:
- Room temperature (25°C): 2 days
- Refrigerated (4°C): 10 days
Recent research confirms that 1 gram ceftriaxone diluted in 100 mL of 0.9% sodium chloride, stored light-protected and refrigerated at 3-4°C, remains stable for up to 10 hours 2.
Special Populations
Neonates (≤28 days):
- Contraindicated if requiring calcium-containing IV solutions 1
- Contraindicated in premature neonates 1
- Must infuse over 60 minutes (not 30) 1
- Avoid in hyperbilirubinemic neonates 1
Pediatric dosing considerations from guidelines 3:
- Neonates ≤7 days and >2000 g: 50-75 mg/kg/day every 24 hours
- Neonates >7 days and >2000 g: 50-75 mg/kg/day every 24 hours
- Infants and children: 50-75 mg/kg/day divided every 12-24 hours
Compatibility Warnings
Incompatible drugs that must never be mixed with ceftriaxone 1:
- Vancomycin
- Amsacrine
- Aminoglycosides
- Fluconazole
If these drugs must be given, administer sequentially with thorough line flushing between administrations 1.
Compatible admixture: Flagyl IV (metronidazole) at concentrations not exceeding 5-7.5 mg/mL with ceftriaxone 10 mg/mL, stable for 24 hours at room temperature only in 0.9% sodium chloride or D5W (do not refrigerate) 1.